JPS5368701A - Callicreinntrypsin inhibition gene derivative * method of producing same and its use - Google Patents

Callicreinntrypsin inhibition gene derivative * method of producing same and its use

Info

Publication number
JPS5368701A
JPS5368701A JP14083877A JP14083877A JPS5368701A JP S5368701 A JPS5368701 A JP S5368701A JP 14083877 A JP14083877 A JP 14083877A JP 14083877 A JP14083877 A JP 14083877A JP S5368701 A JPS5368701 A JP S5368701A
Authority
JP
Japan
Prior art keywords
callicreinntrypsin
producing same
gene derivative
inhibition gene
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14083877A
Other languages
English (en)
Japanese (ja)
Inventor
Shiyunaberu Oigen
Rainharuto Geruto
Deiitaa Shiyurumuberu Horusuto
Torushiyaito Erunsuto
Chieshie Hararuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS5368701A publication Critical patent/JPS5368701A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
JP14083877A 1976-11-29 1977-11-25 Callicreinntrypsin inhibition gene derivative * method of producing same and its use Pending JPS5368701A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762654124 DE2654124A1 (de) 1976-11-29 1976-11-29 Derivate des trypsin-kallikrein-inhibitors aus rinderorganen (bpti) mit proteasenhemmwirkung und antiphlogistischer wirkung, ihre herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
JPS5368701A true JPS5368701A (en) 1978-06-19

Family

ID=5994225

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14083877A Pending JPS5368701A (en) 1976-11-29 1977-11-25 Callicreinntrypsin inhibition gene derivative * method of producing same and its use

Country Status (10)

Country Link
US (1) US4153687A (enExample)
JP (1) JPS5368701A (enExample)
BE (1) BE861267A (enExample)
DE (1) DE2654124A1 (enExample)
DK (1) DK526077A (enExample)
ES (1) ES464571A1 (enExample)
FR (1) FR2373516A1 (enExample)
GB (1) GB1557599A (enExample)
NL (1) NL7713091A (enExample)
SE (1) SE7713436L (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748294A1 (de) * 1977-10-27 1979-05-03 Bayer Ag Neue derivate des bpti, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2748295A1 (de) * 1977-10-27 1979-05-03 Bayer Ag Neue derivate des bpti
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
CA2180950C (en) * 1994-01-11 2005-03-29 William Markland Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
US6057287A (en) * 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
PT737207E (pt) * 1994-01-11 2005-02-28 Dyax Corp Inibidores de plasmina humana derivados de dominios kunitz
US20040054082A1 (en) * 2001-12-03 2004-03-18 Bank David H Toughened polymer blends with improved surface properties
EP2298278B1 (en) 2002-06-07 2015-11-11 Dyax Corp. Prevention and reduction of blood loss and inflammatory response
US7153829B2 (en) * 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
ES2395014T3 (es) 2002-08-28 2013-02-07 Dyax Corp. Métodos para conservar órganos y tejidos
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
US7276480B1 (en) 2005-12-30 2007-10-02 Dyax Corp. Prevention and reduction of blood loss
JP2009529542A (ja) * 2006-03-10 2009-08-20 ダイアックス コーポレーション エカランチドに関する配合物
AU2010203712A1 (en) * 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
ES2905545T3 (es) 2010-01-06 2022-04-11 Takeda Pharmaceuticals Co Proteínas de unión a calicreína plasmática
CN105713092B (zh) 2011-01-06 2019-09-10 戴埃克斯有限公司 血浆前激肽释放酶结合蛋白
WO2012170945A2 (en) 2011-06-10 2012-12-13 Isis Pharmaceuticals, Inc. Methods for modulating kallikrein (klkb1) expression
CA2840614A1 (en) 2011-06-29 2013-01-03 Isis Pharmaceuticals, Inc. Methods for modulating kallikrein (klkb1) expression
RU2712559C9 (ru) 2013-08-28 2020-10-08 Ионис Фармасьютикалз, Инк. Модуляция экспрессии прекалликреина (пкк)
US10428158B2 (en) 2014-03-27 2019-10-01 Dyax Corp. Compositions and methods for treatment of diabetic macular edema
EP4534092A3 (en) 2014-05-01 2025-07-02 Ionis Pharmaceuticals, Inc. Compositions and methods for modulating pkk expression
BR112018011622A2 (pt) 2015-12-11 2018-11-27 Dyax Corp método para tratar ataque de angioedema hereditário (hae) ou reduzir a taxa de ataque de hae

Also Published As

Publication number Publication date
DE2654124A1 (de) 1978-06-01
DK526077A (da) 1978-05-30
GB1557599A (en) 1979-12-12
NL7713091A (nl) 1978-05-31
FR2373516B1 (enExample) 1980-06-13
US4153687A (en) 1979-05-08
BE861267A (fr) 1978-05-29
SE7713436L (sv) 1978-05-30
ES464571A1 (es) 1978-09-01
FR2373516A1 (fr) 1978-07-07

Similar Documents

Publication Publication Date Title
JPS5368701A (en) Callicreinntrypsin inhibition gene derivative * method of producing same and its use
JPS52100784A (en) Pacemaker and method of producing same
JPS5215955A (en) Multiivvpulley and method of producing same
JPS5382562A (en) Zipper and method of producing same
JPS52153151A (en) Capacitor and method of manufacture thereof
JPS5445637A (en) Method of forming hard wearrresistant coating and coating product using same
JPS51119305A (en) Bricket and method of producing same
IL53352A0 (en) Derivatives of thiazolidinecarboxylic acids and related acids
GB1540718A (en) Hard coating and its method of formation
ZA76460B (en) Substituted benzodiazepin-10-ones and method of use
JPS52103058A (en) Multiple passage and method of producing same
JPS52128260A (en) Yolk extender and method of producing same
ZA777062B (en) Derivatives of thiazolidinecarboxylic acids and related acids
JPS5312897A (en) Production of theaflauin and derivative thereof
JPS549154A (en) Forgeddjoint and method of forming same
JPS52108981A (en) Substituted 88hydroxyquinoline and method of preparing same
JPS5330767A (en) Capacitor and method of manufacture thereof
JPS532401A (en) Antibioticsaa3551 and method of preparation thereof
JPS5373539A (en) Derivative of dinitrosulfanilamide and its use and method of production
PH14030A (en) Derivatives of 2-iminothiazolidine and 2-iminothiazoline
JPS51115124A (en) Method of continuous and simultaneous formation
JPS532455A (en) New derivatives of cyclobutaneprostaglandin and process for manufacture thereof
JPS532163A (en) Curtain and method of using same
JPS532418A (en) New glycinamid derivatives and method of its manufacturing
JPS5376915A (en) Reducing method of tetrachlorozirconium